Pershing Square Sells Some Valeant Pharma (VRX)
Tweet
Share
E-mail
Pershing Square sold some Valeant Pharma (NYSE: VRX) shares:
The Reporting Persons sold Common Stock for the accounts of PS and PS II, the two onshore partnerships which are comprised of US taxable investors. PS and PS II sold, respectively, 3,359,178 and 117,512 shares of high-cost-basis Common Stock of the Issuer in order to generate a tax loss in 2016 for their investors. PS International and PSH, the two offshore funds, sold no shares of the Issuer’s Common Stock.
“The Reporting Persons unwound (through a purchase to close transaction) over-the-counter European-style call options referencing a total of 9,120,000 shares of Common Stock which had an expiration date of January 20, 2017.”
Exhibit 99.13
Name | Trade Date | Buy/Sell/ Exercise | No. of Quantity | Unit Cost | Strike Price | Trade Amount | Security | Expiration Date | ||||||||||||||||
Pershing Square, L.P. | December 12, 2016 | Sell | 3,359,178 | $ | 14.85 | N/A | $ | 49,882,706 | N/A | N/A | ||||||||||||||
Pershing Square, L.P. | December 12, 2016 | Buy to Close | 2,531,559 | $ | 0.01 | $ | 165.00 | $ | 25,316 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square II, L.P. | December 12, 2016 | Sell | 117,512 | $ | 14.85 | N/A | $ | 1,745,015 | N/A | N/A | ||||||||||||||
Pershing Square II, L.P. | December 12, 2016 | Buy to Close | 63,122 | $ | 0.01 | $ | 165.00 | $ | 631 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square International, Ltd. | December 12, 2016 | Buy to Close | 2,837,875 | $ | 0.01 | $ | 165.00 | $ | 28,379 | OTC Call Option | January 20, 2017 | |||||||||||||
Pershing Square Holdings, Ltd. | December 12, 2016 | Buy to Close | 3,687,444 | $ | 0.01 | $ | 165.00 | $ | 36,874 | OTC Call Option | January 20, 2017 | |||||||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott Vacations Worldwide (VAC) ticks higher on new activist investor
- Jana, in Letter, Urges Wolfspeed (WOLF) to Eye Sale, Other Strategic Alternatives - Reuters
- Browning West and Glenn Chamandy Comment on Gildan Activewear’s (GIL) Defensive and Reactionary Board Refreshment
Create E-mail Alert Related Categories
13Ds, Hedge Funds, Trader TalkRelated Entities
Pershing Square CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
